|View printer-friendly version|
Charles River Laboratories International Inc. (NYSE:CRL), a leading provider of pre-clinical research products and services to pharmaceutical and biotechnology companies, launched the Endosafe(R)-PTS today. The PTS is a portable test system based on the Limulus Amebocyte Lysate (LAL) assay. The LAL test is used to detect microbial contaminants in injectable drugs and medical devices.
You can reach the story directly by going to http://www.newstream.com/cgi-bin/display_story.cgi?10305
This multimedia news story is for free and unrestricted use on your news information site (and for print or broadcast too). Visit http://www.newstream.com to download video, audio, text, graphics and photos. If you have any questions about the story, or about Newstream.com, please write to us at firstname.lastname@example.org.
CONTACT: Newstream.com, New York email@example.com SOURCE: Newstream and Charles River Laboratories International Inc.